Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition